490 related articles for article (PubMed ID: 12762504)
1. Immunogenicity and immune tolerance coagulation Factors VIII and IX.
Rup B
Dev Biol (Basel); 2003; 112():55-9. PubMed ID: 12762504
[TBL] [Abstract][Full Text] [Related]
2. Immunological aspects of inhibitor development.
Reding MT
Haemophilia; 2006 Dec; 12 Suppl 6():30-5; discussion 35-6. PubMed ID: 17123391
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
4. Inhibitors in young boys with haemophilia.
Lusher JM
Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
[TBL] [Abstract][Full Text] [Related]
5. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
Nilsson IM; Berntorp E
Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
[No Abstract] [Full Text] [Related]
6. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
Mathias M; Khair K; Hann I; Liesner R
Br J Haematol; 2004 May; 125(3):366-8. PubMed ID: 15086418
[TBL] [Abstract][Full Text] [Related]
7. Urgent inhibitor issues: targets for expanded research.
Hoots WK
Haemophilia; 2006 Dec; 12 Suppl 6():107-13. PubMed ID: 17123403
[TBL] [Abstract][Full Text] [Related]
8. Immune tolerance: critical issues of factor dose, purity and treatment complications.
DiMichele DM
Haemophilia; 2006 Dec; 12 Suppl 6():81-5; discussion 85-6. PubMed ID: 17123399
[TBL] [Abstract][Full Text] [Related]
9. Induced immunotolerance in factor VIII inhibitor patients.
Brackmann HH
Prog Clin Biol Res; 1984; 150():181-95. PubMed ID: 6431426
[No Abstract] [Full Text] [Related]
10. Basic aspects of inhibitors to factors VIII and IX and the influence of non-genetic risk factors.
Astermark J
Haemophilia; 2006 Dec; 12 Suppl 6():8-13; discussion 13-4. PubMed ID: 17123388
[TBL] [Abstract][Full Text] [Related]
11. The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy.
Dimichele D
Haemophilia; 2009 Jan; 15(1):320-8. PubMed ID: 18976249
[TBL] [Abstract][Full Text] [Related]
12. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
White GC; Greenwood R; Escobar M; Frelinger JA
Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
[TBL] [Abstract][Full Text] [Related]
13. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
Engelfriet CP; Reesink HW; Mannucci PM; Gringeri A; Ingerslev J; Brettler DB; Mauser-Bunschoten EP; Negrier C; Berntorp E; Smith OP; Shapiro AD
Vox Sang; 2000; 78(4):256-61. PubMed ID: 10970234
[No Abstract] [Full Text] [Related]
14. Inhibitor treatment in haemophilias A and B: inhibitor diagnosis.
DiMichele DM
Haemophilia; 2006 Dec; 12 Suppl 6():37-41; discussion 41-2. PubMed ID: 17123392
[TBL] [Abstract][Full Text] [Related]
15. Animal models of inhibitors.
Reipert B; Arruda V; Lillicrap D
Haemophilia; 2010 Jul; 16 Suppl 5():47-53. PubMed ID: 20590856
[TBL] [Abstract][Full Text] [Related]
16. Overview of inhibitors.
Astermark J
Semin Hematol; 2006 Apr; 43(2 Suppl 4):S3-7. PubMed ID: 16690373
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors in congenital coagulation disorders.
Key NS
Br J Haematol; 2004 Nov; 127(4):379-91. PubMed ID: 15521914
[TBL] [Abstract][Full Text] [Related]
18. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of factors VIII and IX manufactured in Hungary, based on results of the first half year].
Nemes L; Ceglédi A; Szabó G; Varga M; Sas G
Orv Hetil; 1998 Mar; 139(13):749-52. PubMed ID: 9578703
[TBL] [Abstract][Full Text] [Related]
20. How to manage invasive procedures in children with haemophilia.
Ljung RC; Knobe K
Br J Haematol; 2012 Jun; 157(5):519-28. PubMed ID: 22390160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]